Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Total 13F shares
-
111,597,128
-
Share change
-
+18,825,554
-
Total reported value
-
$1,515,160,970
-
Put/Call ratio
-
27%
-
Price per share
-
$13.58
-
Number of holders
-
184
-
Value change
-
+$263,628,807
-
Number of buys
-
122
-
Number of sells
-
55
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2020
As of 30 Jun 2020 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 111,597,128 shares of stock of the company.
Largest 10 holders included BAUPOST GROUP LLC/MA, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Consonance Capital Management LP, Nantahala Capital Management, LLC, ABRAMS CAPITAL MANAGEMENT, L.P., STATE STREET CORP, GREAT POINT PARTNERS LLC, and D. E. Shaw & Co., Inc..
This table shows 184 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.